Leishmaniasis

Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Diagnosis and Treatment of Leishmania Infections

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Mediterranean Visceral Leishmaniasis With Leishmania Infantum

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil

A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies

Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects

Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis

Defining Skin Immunity of a Bite of Key Insect Vectors in Humans

Sodium Stibogluconate Treatment of Leishmaniasis

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes

Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection

Expression of Mif Alleles in Individuals With Leishmaniasis

Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre